---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-009247"
form_type: "8-K"
ticker: "XTNT"
cik: "0001453593"
company_name: "Xtant Medical Holdings, Inc."
filed_at: "2024-03-07T23:59:59+00:00"
generated_at: "2026-06-05T01:23:25.717665+00:00"
event_type: "debt"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Xtant Medical upsizes revolver to $17M, extends maturity to 2029, removes EBITDA covenant

## Summary
- Revolving credit facility increased from $8M to $17M with MidCap Financial.
- Term loan amended to include an additional $10M tranche for acquisitions at MidCap's discretion.
- Maturity of both facilities extended to March 1, 2029.
- Minimum Adjusted EBITDA requirement removed; net product revenue covenants reset.
- Term loan interest margin reduced from 7.00% to 6.50%.

## SEC filing metadata
- accession: 0001493152-24-009247
- form_type: 8-K
- ticker: XTNT
- cik: 0001453593
- company_name: Xtant Medical Holdings, Inc.
- filed_at: 2024-03-07T23:59:59+00:00
- event_type: debt
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 2.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1453593/000149315224009247/0001493152-24-009247-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1453593/000149315224009247/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-009247
- JSON: https://secwatch.observer/filing/0001493152-24-009247.json
- Plain text: https://secwatch.observer/filing/0001493152-24-009247.txt

## Key facts
- Debt Financings
  Xtant Medical Holdings, Inc. amended credit facility of $17,000,000 with MidCap Financial Trust at SOFR Interest Rate plus 6.50% maturing March 1, 2029.
  - Instrument: credit facility
  - Principal: $17,000,000
  - Counterparty: MidCap Financial Trust
  - Rate: SOFR Interest Rate plus 6.50%
  - Maturity: March 1, 2029
  - Event: amendment
  source text: and lenders from time to time party thereto. The Term Credit Agreement provides for a secured term loan facility (the “Term Facility”) in an aggregate principal amount of $17,000,000, which was previously funded under the Prior Term Credit Agreement, and an additional $10,000,000 tranche available solely at the discretion of MidCap Financial Trust and the
  evidence_url: https://www.sec.gov/Archives/edgar/data/1453593/000149315224009247/0001493152-24-009247-index.htm
- Debt Financings
  Xtant Medical Holdings, Inc. amended revolving credit of up to $17,000,000 with MidCap Funding IV Trust at SOFR Interest Rate plus 4.50% maturing March 1, 2029.
  - Instrument: revolving credit
  - Principal: up to $17,000,000
  - Counterparty: MidCap Funding IV Trust
  - Rate: SOFR Interest Rate plus 4.50%
  - Maturity: March 1, 2029
  - Event: amendment
  source text: and lenders from time to time party thereto. The Term Credit Agreement provides for a secured term loan facility (the “Term Facility”) in an aggregate principal amount of $17,000,000, which was previously funded under the Prior Term Credit Agreement, and an additional $10,000,000 tranche available solely at the discretion of MidCap Financial Trust and the
  evidence_url: https://www.sec.gov/Archives/edgar/data/1453593/000149315224009247/0001493152-24-009247-index.htm
- Material Agreements
  Xtant Medical Holdings, Inc. amended Credit Agreements with MidCap Financial Trust and MidCap Funding IV Trust valued at $17,000,000 term facility and $17,000,000 revolving facility (effective 2024-03-07).
  - Action: amendment
  - Agreement: credit facility
  - Counterparty: MidCap Financial Trust and MidCap Funding IV Trust
  - Value: $17,000,000 term facility and $17,000,000 revolving facility
  - Effective: 2024-03-07
  source text: On March 7, 2024 (the “Closing Date”), Xtant Medical Holdings, Inc. (the “Company”), as guarantor, and certain of its subsidiaries, Xtant Medical, Inc., Bacterin International, Inc., X-spine Systems, Inc. and Surgalign SPV, Inc., as borrowers (collectively, the “Borrowers”), entered into (i) an Amended and Restated Credit, Security and Guaranty Agreement (Term Loan) (the “Term Credit Agreement”) with MidCap Financial Trust, in its capacity as agent, and the lenders from time to time party thereto, and (ii) an Amended and Restated Credit, Security and Guaranty Agreement (Revolving Loan) (the “Revolving Credit Agreement” and, together with the Term Credit Agreement, the “Credit Agreements”) with MidCap Funding IV Trust, in its capacity as agent, and the lenders from time to time party thereto.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1453593/000149315224009247/0001493152-24-009247-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.